Chronic thromboembolic pulmonary hypertension during pregnancy is uncommon but is associated with maternal mortality in excess of 35%. We report a case of decompensated thromboembolic pulmonary hypertension requiring emergency caesarean section and postpartum treatment with extracorporeal membrane oxygenation and thrombolytic therapy with urokinase. The use of extracorporeal membrane oxygenation, catheter-directed pulmonary thrombolytic therapy and other pulmonary vasodilators for management of this life-threatening disease is discussed.
BonninM., MercierF.J., SitbonO., Roger-ChristophS., JaisX., HumbertM.Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases.Anesthesiology2005; 102: 1133–1137; discussion 5A-6A.
4.
RochatR.W., KooninL.M., AtrashH.K., JewettJ.F.Maternal mortality in the United States: report from the Maternal Mortality Collaborative.Obstet Gynecol1988; 72: 91–97.
5.
WeissB.M., ZempL., SeifertB., HessO.M.Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.J Am Coll Cardiol1998; 31: 1650–1657.
6.
BedardE., DimopoulosK., GatzoulisM.A.Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?Eur Heart J2009; 30: 256–265.
7.
MaddenB.P.Pulmonary hypertension and pregnancy.Int J Obstet Anesth2009; 18: 156–164.
8.
RosenblumJ.K., CynamonJ.Mechanical and enzymatic thrombolysis of acute pulmonary embolus: review of the literature and cases from our institution.Vascular2008; 16: 213–218.
9.
BechtelJ.J., MountfordM.C., EllinwoodW.E.Massive pulmonary embolism in pregnancy treated with catheter fragmentation and local thrombolysis.Obstet Gynecol2005; 106: 1158–1160.
10.
SofocleousC.T., HinrichsC., BahramipourP., BaroneA., AbujudehH., ContractorD.Percutaneous management of life-threatening pulmonary embolism complicating early pregnancy.J Vasc Interv Radiol2001; 12: 1355–1356.
11.
KrishnamurthyP., MartinC.B., KayH.H., DiesnerJ., FridayR.O., WeberC.A.Catheter-directed thrombolysis for thromboembolic disease during pregnancy: a viable option.J Matern Fetal Med1999; 8: 24–27.
12.
McCotterC.J., ChiangK.S., FearringtonE.L.Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: a review of 26 patients with and without contraindications to systemic thrombolytic therapy.Clin Cardiol1999; 22: 661–664.
ThabutG., ThabutD., MyersR.P., Bernard-ChabertB., Marrash-ChahlaR., MalH.Thrombolytic therapy of pulmonary embolism: a meta-analysis.J Am Coll Cardiol2002; 40: 1660–1667.
15.
GoldhaberS.Z., VisaniL., De RosaM.Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER).Lancet1999; 353: 1386–1389.
KonstantinidesS., TiedeN., GeibelA., OlschewskiM., JustH., KasperW.Comparison of alteplase versus heparin for resolution of major pulmonary embolism.Am J Cardiol1998; 82: 966–970.
18.
SharmaG.V., BurlesonV.A., SasaharaA.A.Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism.N Engl J Med1980; 303: 842–845.
19.
ComeP.C.Echocardiographic evaluation of pulmonary embolism and its response to therapeutic interventions.Chest1992; 101: 151S–162S.
20.
SharmaG.V., FollandE.D., McIntyreK.M.Longterm hemodynamic benefit of thrombolytic therapy in pulmonary embolic disease (abstract).J Am Coll Cardiol1990; 15: 65.
21.
te RaaG.D., RibbertL.S., SnijderR.J., BiesmaD.H.Treatment options in massive pulmonary embolism during pregnancy; a case-report and review of literature.Thromb Res2009; 124: 1–5.
22.
DaviesM.J., ArsiwalaS.S., MooreH.M., KerrS., SosnowskiA.W., FirminR.K.Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism.Ann Thorac Surg1995; 60: 1801–1803.
23.
HsiehP.C., WangS.S., KoW.J., HanY.Y., ChuS.H.Successful resuscitation of acute massive pulmonary embolism with extracorporeal membrane oxygenation and open embolectomy.Ann Thorac Surg2001; 72: 266–267.
24.
MylesP.S., HallJ.L., BerryC.B., EsmoreD.S.Primary pulmonary hypertension: prolonged cardiac arrest and successful resuscitation following induction of anesthesia for heart-lung transplantation.J Cardiothorac Vasc Anesth1994; 8: 678–681.
25.
SatohH., MasudaY., IzutaS., YakuH., ObaraH.Pregnant patient with primary pulmonary hypertension: general anesthesia and extracorporeal membrane oxygenation support for termination of pregnancy.Anesthesiology2002; 97: 1638–1640.
26.
SugiokaJ., NakajimaT., OhsumiH., KuroM., SasakoY.[Anesthetic management using percutaneous cardiopulmonary support for cesarean section in a patient with severe pulmonary hypertension].Masui1995; 44: 574–578.
27.
ArltM., PhilippA., IesalnieksI., KobuchR., GrafB.M.Successful use of a new hand-held ECMO system in cardiopulmonary failure and bleeding shock after thrombolysis in massive post-partal pulmonary embolism.Perfusion2009; 24: 49–50.
BarstR.J., RubinL.J., McGoonM.D., CaldwellE.J., LongW.A., LevyP.S.Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.Ann Intern Med1994; 121: 409–415.
30.
RubinL.J., MendozaJ., HoodM., McGoonM., BarstR., WilliamsW.B.Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.Ann Intern Med1990; 112: 485–491.
31.
BarstR.J., RubinL.J., LongW.A., McGoonM.D., RichS., BadeschD.B.A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.N Engl J Med1996; 334: 296–302.
32.
ShapiroS.M., OudizR.J., CaoT., RomanoM.A., BeckmannX.J., GeorgiouD.Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.J Am Coll Cardiol1997; 30: 343–349.
33.
HigenbottamT., ButtA.Y., McMahonA., WesterbeckR., SharplesL.Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension.Heart1998; 80: 151–155.
34.
McLaughlinV.V., GenthnerD.E., PanellaM.M., HessD.M., RichS.Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series.Ann Intern Med1999; 130: 740–743.
35.
RichS., McLaughlinV.V.The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.J Am Coll Cardiol1999; 34: 1184–1187.
36.
BeckJ.R., MongeroL.B., KroslowitzR.M., ChoudhriA.F., ChenJ.M., DeRoseJ.J.Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery.Perfusion1999; 14: 37–42.
37.
Pepke-ZabaJ., HigenbottamT.W., Dinh-XuanA.T., StoneD., WallworkJ.Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.Lancet1991; 338: 1173–1174.
38.
MathaiS.C., GirgisR.E., FisherM.R., ChampionH.C., Housten-HarrisT., ZaimanA.Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.Eur Respir J2007; 29: 469–475.
